Each stage in the life cycle of a product has its unique requirements. These are even more challenging when your drug is based on an already established active ingredient. Our client offers an improved formulation of a well-known chemotherapy and has a wealth of pre-clinical and clinical data supporting the use of this liposomal formulation that minimizes the risk of cardiotoxicity.